StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note released on Monday. The firm issued a hold rating on the software maker’s stock.
Veradigm Price Performance
MDRX stock opened at $10.40 on Monday. The business has a 50 day simple moving average of $9.76 and a 200-day simple moving average of $9.50. Veradigm has a twelve month low of $5.01 and a twelve month high of $12.66.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new position in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- Top Stocks Investing in 5G Technology
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Best Stocks Under $10.00
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Where to Find Earnings Call Transcripts
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
